Lastly, an in vivo mouse model silencing Tgm2 in CD11b myeloid cells in HFD mice further demonstrated that reducing TGM2 in myeloid cells results in increased pro-inflammatory responses, along with increased obesity and IR. Here, TGM2 is linked to obesity disorder.